Zynerba Pharmaceuticals to Participate in Upcoming Investor Meetings and Conferences
DEVON, Pa., June 01, 2016 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the Company will …